With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image Source: Getty Images
Appen Ltd (ASX: APX)
According to a note out of Citi, its analysts have retained their buy rating but cut their price target on this AI data services company's shares by 38% to $9.15. Citi appears concerned by the lack of earnings visibility after Appen decided against providing short term guidance. However, it feels the share price decline has been an overreaction. And while the broker isn't convinced the company will achieve its FY 2026 targets, it still sees enough value to maintain its buy rating. The Appen share price is trading at $7.02 this afternoon.
GQG Partners Inc (ASX: GQG)
A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this fund manager's shares with a price target of $2.33. Goldman highlights that GQG delivered a full year profit result ahead of prospectus forecasts thanks to a much better than expected performance on costs. Overall, it believes GQG shares are a buy due to strong operating momentum, low fees, and management having significant skin in the game. The GQG share price is fetching $1.46 today.
Medibank Private Ltd (ASX: MPL)
Analysts at Morgans have upgraded this private health insurer's shares to an add rating with a $3.43 price target. This follows the release of the company's half year results, which came in ahead of consensus estimates. In addition, Morgans believes the benign claims environment is favourable and sees positives from its productivity program. The Medibank share price is trading at $3.18 on Monday afternoon.
